doi:10.3969/j.issn.1673-8640.2015.05.027

Abstract

CLC Number:

R446.5

Figures/Tables 3

References 12

[1]	陈宏斌,张小江,赵颖,等.卫生部全国细菌耐药监测网(Mohnarin)2009年度报告:ICU来源细菌耐药监测[J].中国临床药理学杂志,2011,27(7):483-489.
[2]	杨万春,王勇.我院2006-2008年常见细菌分布及耐药性分析[J].临床肺科杂志,2009,14(12):1692-1693.
[3]	卓超,苏丹虹,倪语星,等.2009年中国CHINET大肠埃希菌和克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):430-435.
[4]	张妍蓓,何凤莲,方明,等.常见革兰阴性杆菌的耐药性分析[J].中华医院感染学杂志,2009,19(9):1143-1145.
[5]	彭晓燕,姚冰,李晓波.2009-2011年医院革兰阴性菌分布及耐药性分析[J].西北药学杂志,2013,28(2):201-203.
[6]	张小江,徐英春,俞云松,等.2009年中国CHINET鲍曼不动杆菌细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):441-446.
[7]	熊燕,张虹,陈炎添,等.多重耐药菌感染的临床分析和耐药性监测[J].中国基层医药,2013,20(1):26-28.
[8]	薛欣盛,王波,邓丽静,等.碳青霉烯抗菌药物处方限制策略对呼吸机相关性肺炎多药耐药鲍曼不动杆菌发生率的影响[J].中国危重病急救医学,2009,21(4):234-236.
[9]	于清华. 沙雷菌医院感染特点及对常用抗菌药物的耐药性分析[J].医学理论与实践,2009,22(5):613-614.
[10]	任南,文细毛,徐秀华,等.沙雷菌属医院感染的分布特征及耐药性分析[J].中华医院感染学杂志,2005,15(3):342-344.
[11]	石华,徐述雄,李凯,等.泌尿外科住院患者尿路感染的病原菌分布及耐药性分析[J]. 中华医院感染学杂志, 2015,7(14):3524-3526.
[12]	BOULTON AJ,VILEIKYTE L,RAGNARSON-TENNVALL G,et al.The global burden of diabetic foot disease[J]. Lancet,2012,366(9498):1719-1723.

G^-菌	2011年	2012年	2013年	总计
鲍曼不动杆菌	750(15.92)	740(15.71)	880(18.68)	2 370(50.32)
铜绿假单胞菌	280(5.94)	450(9.55)	400(8.49)	1 130(23.99)
肺炎克雷伯菌	150(3.18)	170(3.61)	220(4.67)	540(11.46)
大肠杆菌	100(2.12)	160(3.40)	140(2.97)	400(8.49)
液化沙雷菌	70(1.49)	90(1.91)	110(2.34)	270(5.74)

G^-菌	2011年	2012年	2013年	总计
鲍曼不动杆菌	750(15.92)	740(15.71)	880(18.68)	2 370(50.32)
铜绿假单胞菌	280(5.94)	450(9.55)	400(8.49)	1 130(23.99)
肺炎克雷伯菌	150(3.18)	170(3.61)	220(4.67)	540(11.46)
大肠杆菌	100(2.12)	160(3.40)	140(2.97)	400(8.49)
液化沙雷菌	70(1.49)	90(1.91)	110(2.34)	270(5.74)

抗菌药物	鲍曼不动杆菌			铜绿假单胞菌			肺炎克雷伯菌			大肠埃希菌			液化沙雷菌
抗菌药物	2011	2012	2013	2011	2012	2013	2011	2012	2013	2011	2012	2013	2011	2012	2013
亚胺培南	68.3	63.1	41.4	71.2	68.7	52.5	100	100	100	100	100	100	100	100	100
美罗培南	-	74.1	68.3	-	64.5	60.3	-	73.2	41.3	-	100	67.7	-	-	-
头孢哌酮/舒巴坦	62.1	53.3	51.6	50.4	48.8	41.4	83.4	73.4	61.3	90.9	85.8	82.9	84.4	89.4	81.3
头孢西丁	-	-	-	-	-	-	71.2	73.4	78.3	74.8	79.8	74.9	68.5	62.9	65.7
头孢吡肟	53.2	36.7	31.6	50.4	44.5	31.5	54.5	43.7	35.8	33.7	35.8	30.9	71.5	71.7	72.7
头孢噻肟	-	-	-	-	-	-	43.4	55.8	41.7	32.6	34.9	39.8	50.8	61.7	52.6
头孢曲松	-	-	-	-	-	-	58.7	50.8	42.8	31.5	34.9	29.7	63.4	62.5	50.7
头孢呋辛	-	-	-	-	-	-	23.5	41.7	31.7	26.9	29.6	21.6	38.4	41.5	54.7
哌拉西林/他唑巴坦	58.4	38.1	22.8	68.4	61.5	44.7	87.7	84.6	81.8	88.9	91.7	92.7	78.7	70.8	82.8
氨曲南	13.7	11.6	9.4	40.4	37.5	29.5	60.9	56.7	40.9	31.7	34.8	28.9	67.9	54.5	62.8
氨苄西林/舒巴坦	19.5	35.7	26.7	-	-	-	29.7	25.7	24.8	27.9	14.5	22.8	27.6	16.4	23.5
哌拉西林	58.6	37.9	21.7	48.7	47.3	28.8	39.9	32.7	28.9	11.7	12.7	11.8	55.6	37.9	45.9
庆大霉素	44.8	31.8	9.4	48.3	42.8	35.6	57.9	60.9	53.7	35.8	37.9	27.9	67.6	56.4	43.5
妥布霉素	-	-	-	57.6	56.4	53.5	30.9	56.8	45.8	33.8	33.3	32.8	35.6	50.3	38.1
左氧氟沙星	52.3	31.5	17.5	55.4	54.4	50.7	64.7	81.8	59.9	36.7	44.3	38.9	77.9	80.9	73.7
环丙沙星	43.4	13.4	8.8	68.6	61.5	42.6	48.9	57.8	58.9	32.7	38.9	33.4	38.7	50.8	38.9
氯霉素	8.9	23.1	9.6	-	-	-	46.7	59.8	48.9	65.7	58.6	53.6	77.8	62.7	71.7
复方磺胺甲噁唑	-	-	-	-	-	-	37.8	52.7	41.7	25.7	27.9	26.6	57.6	56.4	53.5
四环素	6.5	12.5	8.6	-	-	-	46.9	31.6	41.8	18.9	21.7	19.4	12.5	13.4	14.4
米诺环素	32.5	21.7	15.6	-	-	-	-	-	-	-	-	-	-	-	-

抗菌药物	鲍曼不动杆菌			铜绿假单胞菌			肺炎克雷伯菌			大肠埃希菌			液化沙雷菌
抗菌药物	2011	2012	2013	2011	2012	2013	2011	2012	2013	2011	2012	2013	2011	2012	2013
亚胺培南	68.3	63.1	41.4	71.2	68.7	52.5	100	100	100	100	100	100	100	100	100
美罗培南	-	74.1	68.3	-	64.5	60.3	-	73.2	41.3	-	100	67.7	-	-	-
头孢哌酮/舒巴坦	62.1	53.3	51.6	50.4	48.8	41.4	83.4	73.4	61.3	90.9	85.8	82.9	84.4	89.4	81.3
头孢西丁	-	-	-	-	-	-	71.2	73.4	78.3	74.8	79.8	74.9	68.5	62.9	65.7
头孢吡肟	53.2	36.7	31.6	50.4	44.5	31.5	54.5	43.7	35.8	33.7	35.8	30.9	71.5	71.7	72.7
头孢噻肟	-	-	-	-	-	-	43.4	55.8	41.7	32.6	34.9	39.8	50.8	61.7	52.6
头孢曲松	-	-	-	-	-	-	58.7	50.8	42.8	31.5	34.9	29.7	63.4	62.5	50.7
头孢呋辛	-	-	-	-	-	-	23.5	41.7	31.7	26.9	29.6	21.6	38.4	41.5	54.7
哌拉西林/他唑巴坦	58.4	38.1	22.8	68.4	61.5	44.7	87.7	84.6	81.8	88.9	91.7	92.7	78.7	70.8	82.8
氨曲南	13.7	11.6	9.4	40.4	37.5	29.5	60.9	56.7	40.9	31.7	34.8	28.9	67.9	54.5	62.8
氨苄西林/舒巴坦	19.5	35.7	26.7	-	-	-	29.7	25.7	24.8	27.9	14.5	22.8	27.6	16.4	23.5
哌拉西林	58.6	37.9	21.7	48.7	47.3	28.8	39.9	32.7	28.9	11.7	12.7	11.8	55.6	37.9	45.9
庆大霉素	44.8	31.8	9.4	48.3	42.8	35.6	57.9	60.9	53.7	35.8	37.9	27.9	67.6	56.4	43.5
妥布霉素	-	-	-	57.6	56.4	53.5	30.9	56.8	45.8	33.8	33.3	32.8	35.6	50.3	38.1
左氧氟沙星	52.3	31.5	17.5	55.4	54.4	50.7	64.7	81.8	59.9	36.7	44.3	38.9	77.9	80.9	73.7
环丙沙星	43.4	13.4	8.8	68.6	61.5	42.6	48.9	57.8	58.9	32.7	38.9	33.4	38.7	50.8	38.9
氯霉素	8.9	23.1	9.6	-	-	-	46.7	59.8	48.9	65.7	58.6	53.6	77.8	62.7	71.7
复方磺胺甲噁唑	-	-	-	-	-	-	37.8	52.7	41.7	25.7	27.9	26.6	57.6	56.4	53.5
四环素	6.5	12.5	8.6	-	-	-	46.9	31.6	41.8	18.9	21.7	19.4	12.5	13.4	14.4
米诺环素	32.5	21.7	15.6	-	-	-	-	-	-	-	-	-	-	-	-

[1]	. [J]. Laboratory Medicine, 2023, 38(7): 692-695.
[2]	FANG Yongmei, ZHANG Yan, XU Xueying, ZHONG Feng. Correlation of Staphylococcus aureus drug resistance with drug resistance genes and virulence genes [J]. Laboratory Medicine, 2023, 38(4): 357-361.
[3]	LIU Congcong, LI Jiaping, ZHOU Hongwei. Performance evaluation of 2 mass spectrometry systems in clinical microbial identification [J]. Laboratory Medicine, 2022, 37(11): 1084-1088.
[4]	. [J]. Laboratory Medicine, 2022, 37(10): 952-954.
[5]	LI Renqiang, LUO Junfeng, CHEN Yundi. Establishment and evaluation of α-thalassemia and β-thalassemia mutation determinations using hetero-tail dual-labeled fluorescent probe hydridization [J]. Laboratory Medicine, 2022, 37(10): 955-962.
[6]	BAO Hailin, HUA Hongyan, SUN Hengliang, LIU Hua, JI Shunnian, QIN Chenhao, DU Hong. Rapid identification of carbapenemase producing Enterobacteriaceae phenotypes by modified Carba Np test and mCIM/eCIM test [J]. Laboratory Medicine, 2022, 37(10): 963-968.
[7]	YANG Xi, SONG Wenqi, DONG Fang, MENG Qingying, ZHEN Jinghui, ZHOU Wei. Application of Gram staining and MALDI-TOF MS in the rapid identification of pathogen kinds in children's positive blood culture [J]. Laboratory Medicine, 2022, 37(10): 969-973.
[8]	WANG Lixin, SU Yunfu, WANG Yi. Research progress on the drug resistance mechanism of clinical pathogens to fosfomycin [J]. Laboratory Medicine, 2022, 37(10): 993-997.
[9]	YANG Xiaolan, HU Zengjun, WANG Shengqing, MA Shuxia, ZENG Yongjie, WANG Chenglei. Distribution of some common intestinal bacteria in elderly patients with acute cerebral infarction and its correlation with cognitive function [J]. Laboratory Medicine, 2022, 37(9): 839-843.
[10]	HAO Jiahui, YANG Zehua. Research progress of bacterial integron determination methods [J]. Laboratory Medicine, 2022, 37(9): 887-891.
[11]	LI Kun, ZHANG Guojun. Research progress of carbon quantum dots and graphene quantum dots in sensing field [J]. Laboratory Medicine, 2022, 37(8): 787-792.
[12]	CHEN Hanlu, WU Shenghai. Influence factors of blood culture negative results and progress of pathogen detection in bloodstream infection [J]. Laboratory Medicine, 2022, 37(7): 688-694.
[13]	DU Jinghui, HUANG Zikun, LIU Min, GONG Jingjing, WANG Dan, LIU Jibo, LIU Xu. Rapid determination of minimum inhibitory concentration and cut-off concentration of Mycobacterium tuberculosis by nitrate reductase assay using liquid medium [J]. Laboratory Medicine, 2022, 37(6): 568-576.
[14]	WEN Qinghui, LI Fengying, LI Yanchang, HUANG Jinyin, WANG Fengping. Drug susceptibility of multidrug-resistant ESBL-producing Escherichia coli to antimicrobial agents restored by different concentrations of EDTA [J]. Laboratory Medicine, 2022, 37(3): 205-208.
[15]	CHU Minjun, LI Xiaojuan, HUANG Hailin, LI Jue, MA Mingbiao, DU Tingyi, WANG Haiping. Influence of delayed entry on fastidious bacterium culture in 2 blood culture systems [J]. Laboratory Medicine, 2022, 37(3): 209-212.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 12

Related Articles 15

Recommended Articles

Metrics